NCT04590638View on ClinicalTrials.gov

Comparison Between Effect of Adrenaline and Without Adrenaline in Tumescent Solutions on Bleeding Control of Skin Graft Donor Site.

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 17, 2020

Primary Completion Date

March 17, 2021

Study Completion Date

March 17, 2021

Conditions
Bleeding Time
Interventions
OTHER

tumescent with adrenaline

skin graft donor site of patients enrolled in this group will be injected subcutaneously with tumescent solution containing adrenaline to see the bleeding control of donor site.

OTHER

tumescent without adrenaline

skin graft donor site of patients enrolled in this group will be injected subcutaneously with tumescent solution not containing adrenaline to see the bleeding control of donor site.

Trial Locations (1)

1234

Mahak, Karachi

All Listed Sponsors
lead

Dow University of Health Sciences

OTHER

NCT04590638 - Comparison Between Effect of Adrenaline and Without Adrenaline in Tumescent Solutions on Bleeding Control of Skin Graft Donor Site. | Biotech Hunter | Biotech Hunter